The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Application of "Evicel" hemostatic matrix during operation for unilateral total knee
replacement surgery (TKA) will result in decreased bleeding and postoperative drain output, a
reduction in transfusion requirements, and less reduction of hemoglobin.